SS
VTYX

Simplicity Solutions’s Ventyx Biosciences VTYX Stock Holding History

Simplicity Solutions’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$80.6K Buy
+32,628
New +$310K ﹤0.01% 1026

Other funds holding VTYX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Simplicity Solutions's VTYX Position: Q4 2023 in Review

Simplicity Solutions opened a new position in Ventyx Biosciences (VTYX) in Q4 2023: 32,628 shares worth $80.6K. The stake represents ﹤0.01% of the portfolio and ranks #1026 among its holdings.

121 funds tracked by Wall St. Rank hold VTYX as of Q4 2023.

  • Simplicity Solutions held 32,628 shares of Ventyx Biosciences worth $80.6K as of Q4 2023.
  • Ventyx Biosciences was a new Simplicity Solutions position in Q4 2023.
  • Ventyx Biosciences made up ﹤0.01% of Simplicity Solutions's portfolio in Q4 2023, its #1026 holding.
  • 121 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.